Paradigm is a global biopharmaceutical company driven to discover to improve patients’ health and quality of life
Paradigm Biopharmaceuticals has raised $10.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.
Paradigm Biopharmaceuticals's investors include Obsidian Global Partners.
Paradigm Biopharmaceuticals is headquartered in Melbourne, Australia.
Paradigm is a global biopharmaceutical company driven to discover to improve patients’ health and quality of life
Paradigm Biopharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Paradigm Biopharmaceuticals — Funding & Investors." VCBacked, April 27, 2026, https://www.vcbacked.co/company/paradigm-biopharmaceuticals. Accessed August 13, 2026.
VCBacked. (2026). Paradigm Biopharmaceuticals — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/paradigm-biopharmaceuticals
{{cite web |title=Paradigm Biopharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/paradigm-biopharmaceuticals |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated